Latest news
Aurinia Pharmaceuticals (NASDAQ:AUPH) Downgraded by Wall Street Zen to Buy - MarketBeatMarketBeat · Sat, 08 Aug 2026 05:35:23 GMTAurinia Pharmaceuticals (AUPH) Stock Looks Cheap But Earnings Quality Clouds View - simplywall.stsimplywall.st · Sat, 08 Aug 2026 04:28:55 GMTAurinia Pharmaceuticals Announces Q2 2026 Financial Results with Strong Revenue and Income Growth - Kalkine MediaKalkine Media · Thu, 06 Aug 2026 17:38:32 GMTAurinia Pharmaceuticals (AUPH) Surpasses Q2 Earnings Estimates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 13:50:08 GMTAurinia: Q2 Earnings Snapshot - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 12:11:26 GMTAUPH: Strong revenue and net income growth driven by LUPKYNIS, with robust 2026 outlook - TradingViewTradingView · Thu, 06 Aug 2026 12:06:38 GMTBRIEF-Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million - TradingViewTradingView · Thu, 06 Aug 2026 12:01:01 GMTAurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Provides Update on Recent Business Progress - Business WireBusiness Wire · Thu, 06 Aug 2026 12:00:00 GMT